Page 7

The Laboratory Report - Summer 2014

THE LABORATORY REPORT Summer 2014 Pathology Automation: New Equipment Added to Houston Methodist Laboratories Page 7 Dr. Arthur Zieske The Houston Methodist Clinical Laboratory automated its hematology processing line by adding a modular Sysmex XN-series analyzer, which is built on a breakthrough platform known as Silent Design. The new technology offers an automated analysis of body fluid cell counts, slide making and staining, cell image analysis, and tube cell sorting. Moreover, Sysmex XN provides a standardized platform that significantly improves testing consistency. For more information about the Sysmex technology, please contact Dr. Arthur Zieske at awzieske@houstonmethodist.org The Houston Methodist Rapid Response Laboratory added a highly sophisticated Cobas 8000 analyzer by Roche/ Hitachi. This instrument is designed for high-throughput laboratories and is capable of processing 3-15 million clinical chemistry and immunochemistry tests per year. For example, the new analyzer can complete an immunoassay in less than 9 minutes and averages about 1,000 samples per hour, thereby ensuring rapid availability of all patient test results. For more information about the Cobas technology, please contact Dr. Ping Wang at pwang@houstonmethodist.org Dr. Ping Wang Department Awards Internal Grants The Department of Pathology and Genomic Medicine has recently invited its faculty to submit research proposals for small, internal research grants. These microgrants are designed to foster innovation and expansion of clinical service. Each selected project receives a budget, and the work must be started and completed within 3-4 months. The Department’s microgrant review committee is pleased to announce that two proposals have been chosen for funding: “Association of histologic and immunophenotypic features of cervical dysplasia with infection by various HPV genotypes,” submitted by Drs. Yimin Ge, Steven Zhou, Christi Perez, Dina Mody, and Michael Deavers “Prognostic and predictive biomarkers in metastatic rectal adenocarcinoma,” submitted by Drs. Suzanne Crumley, Mary Schwartz, Alexandria Phan, Randall Olsen, and Bryce Portier While the proposal submission deadline expired on July 15th, it is anticipated that the next call for proposals will be announced in mid-to-late August.


The Laboratory Report - Summer 2014
To see the actual publication please follow the link above